Natural health alternatives for HRT to combat menopausal symptoms

The Natural Doctor, Nyjon Eccles, explains the benefits of Bio-Identical Hormone Replacement Therapy

menopausal woman

For years, HRT has been the preferred option offered to women to help address their hormone imbalances and keep menopausal symptoms at bay. Dr Nyjon Eccles, The Natural Doctor and a specialist in natural women’s health addresses other options that are now available to women and talks through the correct steps needed to help women get a full diagnostic picture before they make any decisions. 

HRT for many women is no longer a preferred option whether this be due to the negative press and risks that have been attributed to talking it but suffering and soldering through the menopause is also not an option for many women as life can be horrendous and the emotional and physical symptoms often begin between the ages of 45 and 55.

Dr Eccles takes a look at an advanced hormone balancing treatment called Bio-Identical Hormone Replacement Therapy, which works by supplying your body with adequate levels of key hormones like oestrogen and progesterone and testosterone. BHRT is suitable for both men and women and works by restoring deficiencies of the key hormones it needs by using compounds that have the exact same chemical and molecular structure as those naturally found in the body. Like HRT, Bio-Identical hormones relieve the symptoms of hormone imbalance and menopause and improve quality of life and well-being.

Dr Eccles says, “Each person must have a hormone assessment test before they begin BHRT treatment which involves a comprehensive baseline hormone test that includes a urine, blood, or saliva test so we can check the following:

Oestrogen, progesterone, pregnenolone, testosterone, DHEA, Vitamin D (a hormone not a vitamin). In addition, I also look at cholesterol, which is important for hormones, plus we look at cardiovascular risks and markers for inflammation and all of this then gives me a lot of useful additional information about the patient’s physiology. Once I know what all these hormone levels are and if they are deficient we look at ways of restoring these levels which will help improve positive physiological benefits.”

When should you do this test?

Timing of when to do the hormone panel test depends on whether a woman is still menstruating and if they are no longer menstruating then any time is fine but if they still have a regular cycle then they should do the test day 19 to 21 days into their cycle.

Who should consider BHRT /natural hormone replacement therapy?

•     Suffer from moderate to severe hot flashes

•     Have reduced bone mass

•     Have premature menopause (before the age of 40) or suffer from premature ovarian insufficiency

•     Experience other menopausal symptoms

•     Who have emotional symptoms and mood swings associated with menopause

•     Have loss of libido

•     Have poor concentration and brain fog

•     Want to help support their skin collagen

How is BHRT taken/administered?

In bio-identical hormone replacement therapy, the hormones can be administered in different ways. The hormones are available as:

  • Topical gels or creams (the preferred method)
  • Vaginal creams, rings, and tablets
  • Orally

 

What hormones are actually used in BHRT?

Women’s bodies have many different hormones and estrogen is a group of compounds but BHRT focuses on key hormones such as:

Estrogens

 Recognized as one of the primary female sex hormones, estrogens are a group of compounds that play a crucial role in women’s menstrual and reproductive cycles. As far as structural changes go, estrogens help:

  • Accelerate one’s metabolism (always good for losing weight)
  • Improve brain function
  • Minimize bone reabsorption while increasing bone formation
  • Keep the vagina moist and more youthful
  • Keeps skin more supple and youthful
  • And MORE

In bio-identical hormone replacement therapy, two types of estrogen are prescribed most of the time. They are:

Estradiol

For pre-menopausal women, estradiol comprises the majority of estrogen that the body produces. It serves as a growth hormone for tissues of the reproductive organs – adding more support to the lining of the vagina, fallopian tube, the cervical glands, and the endometrium.

Estriol

Produced by the body during pregnancy but also an important estrogen in pre-menopausal women, this hormone has been used to minimize the symptoms of multiple sclerosis in pregnant women.

Progesterone

This hormone, which can be used orally or transdermally, has been approved by the FDA for treating endometrial hyperplasia and for relieving menopausal symptoms. Moreover, it has been proven to be extremely reliable in treating menopausal sleep problems.

Why consider Bio-Identical Hormone Replacement Therapy

  • Safe and effective relief from menopausal symptoms like decreased sex drive, night sweating, hot flashes, mood swings, etc.
  • Higher energy levels
  • Better metabolism and decreased body fat
  • Increased bone mass
  • Enhanced immune system
  • Better-looking skin
  • Devoid of the side effects of synthetic hormones

 

How long do you need to take it for?

This really depends on what the reason is they are taking them for. Most women elect to keep taking them to get the functional and anti-ageing benefits afforded by being on them. Advantage – No known downsides as with the synthetic hormones. Yearly monitoring is important in any event.

How much does it cost?

Depending on what hormone you need each hormone is about £50 each and on average three to four are prescribed per month.

Dr Eccles believes, “The overall positives of natural hormones is they don’t have some of the downsides that synthetic hormones may have.”

Finally Dr Eccles says “Bio-identical hormone replacement therapy can be an effective remedy against menopausal symptoms … but only if it’s administered in a way that suits the individual and that’s why the correct testing is needed and patients need to monitored and to get the levels optimal for that individual.”

Our review of Dr Nyjon Eccles; The Natural Doctor

The Natural Doctor, Harley Street, Nyjon Eccles, nutritional, hormonal, anti-ageing medicine

The Natural Doctor’s clinic on Harley Street, where he offers nutritional, hormonal and anti-ageing medicine

The quick read: An expert in nutritional, hormonal and anti-ageing medicine. Dr Nyjon Eccles has spent many years studying and researching natural and non-invasive ways to improve cellular health. His mission is to empower people to better health, mainly by testing people for things not routinely tested by their GPs and advising on supplementation. He set up The Natural Doctor at 69 Harley Street in 1998 to specialise in breast health and cancer support work, and he devises nutritional programmes for private clients all over the world suffering from conditions such as hormonal imbalance, adrenal fatigue and diabetes. You can have sessions with him at his clinic on Harley Street, or by Skype or telephone.

smallest pink logoHow was it for us: I first encountered Dr Eccles in a telephone consultation before embarking on a de-stress retreat at Verdura spa in Sicily – though he is an independent doctor, he advises the spa on their wellbeing programmes. ‘How are you?’ was his very first question, which he asked in a gentle voice. ‘Tired’, I said, not quite realising until then just how tired I really was. Years of travelling as a journalist and firing on all cylinders in my life in general had given me a certain feeling of tiredness that I couldn’t explain away anymore by a couple of restless nights sleep. But real help was at hand, for this wasn’t just a chat based on feelings – Dr Eccles had my real blood, saliva and urine test results in front of him on which to base his advice, from carefully devised DIY tests I’d done at home in Devon.

Dr Eccles explained that I was suffering from a low ratio of DHEA in my blood, the youth-giving, anti-ageing parent hormone that declines when we are stressed and as we get older, but that gives us hormone and adrenal support and helps regulate many of our other hormones (which is why it’s a supplement favoured by anti-ageing experts). Increasing my DHEA levels would support my adrenals and make me less tired, he said – and it was a relief to hear there was something practical I could do instead of wondering about why a good sleep the night before hadn’t already cured me of my tiredness.

Classified as a medicine in the UK, DHEA is only available on prescription, so I was slightly wary of it. But Dr Eccles reassured me that the only side effect was oily skin, that he himself had been taking it for years, and that it was available over the counter in the US. (He provides his own pharmaceutical grade supplements to his UK clients, but also suggested that Life Extension are his tried and trusted brand of choice).

It turned out I was also low in Vitamin D, Iodine and Omega 3 – typical, in fact, of most westerners. ‘If we all ate more like the Japanese, we’d be far more healthy’, said Dr Eccles. He advised me to eat more seaweed (particularly kelp) to increase my iodine levels, and to embark on a course of supplements to increase the levels of DHEA, Vitamin D and Omega 3 in my body.

I have gone on to have two more sets of blood tests, three months apart, and two more phone consultations with Dr Eccles, to check the levels each time, and my journey continues. The idea is that slowly, over time, I will change my physiology and take stress off my system. I’ve always found him to be friendly, kind, straight up and with a generous sense of humour. And I’ve also learnt some marvellously interesting things.

The Natural Doctor, Nyjon Eccles The Natural Doctor, Nyjon Eccles

Over 70% of people in the western word are deficient in Vitamin D, for example, which is vital for immune and bone support and to protect the heart and nervous system – yet it’s not routinely tested by GPs. About 50% of Europeans are also deficient in iodine, mainly because of diet, and we’re also usually low in Omega 3 and should be taking at least 2.5g of it a day – more if we already have an existing inflammatory condition such as arthritis or bowel disorder.

What fascinates me most is that Dr Eccles is doing what I think my GP should be doing anyway – checking, on a cellular level, how my body really is, routinely measuring physiological imbalances and correcting these imbalances to reduce my risk of ill health and today’s degenerative diseases. I live in hope.

More on Dr Eccles: Nyjon has an excellent reputation for his practice of evidence-based Complementary Medicine, and is one of the leading Integrated Medicine Physicians in the UK – he is acknowledged in “Who’s Who” in Medicine & Healthcare, 2011-2012, for outstanding contributions in the Medical field, and received a Medical Science Award of Excellence 2011 for Natural Medicine Research. He is also pioneering the introduction to the UK of Medical Infrared BreastThermal Imaging, for very early non-invasive detection of breast cancer and screening of musculoskeletal disorders.

crown What’s queenly: Dr Eccles is an advisor for some health retreats – including the wellbeing programmes run by Verdura spa in Sicily and the healing programmes on offer at Amchara detox retreat in Somerset.

What’s lowly: If you’re doing blood tests at home, you might need some patience – there’s something excruciating about pricking your own finger and dropping your blood onto a piece of card.

Prices: Introductory consultations cost £250, either in person, by telephone or via Skype. Follow ups are £200 at the clinic or £150 via tel/Skype.

 

Winning the War on Cancer

In the last article “Losing the War on Cancer” I discussed the current failure of chemotherapy to turn the tide of increasing incidence of cancer. I looked at the reasons why this was the case. I discussed the clues from Nature that suggest that the cancer prevention actions of the phyto-nutrients in fruit and vegetables are likely to be due to a range of nutrient-gene interactions and not just an anti-oxidant effect. Specific phyto-nutrients decrease DNA damage, improve cell communication, improve cell detoxification, are anti-inflammatory, boost Immunity and improve circulation and there may be other as yet undefined actions of phyto-nutrients that are relevant to their cancerostatic effect.

The key to unravelling the cancer mystery I believe lies in correctly identifying the mechanisms by which a normal regulated cell becomes an “unruly” unregulated one.

The cell is an exceedingly complicated and subtle machinery in which all functions are carefully regulated. A normal cell divides only when division is needed. A cancer cell divides also when no division is needed. This means that the cell regulators are out of order. Many efforts to show the difference between the chemical makeup of a normal and a cancer cell have hitherto failed. The cellular structures are identical, only the regulators are disturbed. Something has gone wrong that has to be repaired.

How does a normal cell become unregulated?

In recent years there has been a great deal of focus on the possible assaults on a cell that may cause it to mutate and become abnormal. Does a virus or a toxin or free radical cause damage to DNA and lead to an alteration in the cells regulatory genes, for example those involved in normal programmed cell death. Interesting though this is in theory, it has not led to any major solution to the cancer problem.

There have been some historical clues to suggest that a fundamental flaw that occurs in all cancers is a disturbance in cell metabolism, that makes the cell prefer a fermentation of glucose (using glycolysis) for energy production rather than the more efficient oxidative metabolism (which requires oxygen and generates much more energy). (Warburg,1930; Szent-Gyorgyi et al, 1963). It seems that this switch to fermentation may be a mechanism for allowing cell division and therefore growth to occur and may be the process that normally happens when the cell needs to divide. After this normal cell division the process then reverts back to oxidative metabolism, with its associated electron flow, and which requires a more organised cell structure. Therefore, it may be that the uncontrolled growth of cancer cells is associated with them being stuck in a fermentation process. We must then ask the question – What keeps them stuck in this process? Or what turns off the ability of the cell to revert back to a normal oxidative cell metabolism – which seems to be associated with cell regulation?

These arguments are not new and have been presented before by Albert Szent- Gyorgyi, the Hungarian-born Nobel prizewinner, in the 1950s and 60s. (Dr. Albert Szent-Gyorgyi was the Nobel Laureate in Medicine in 1937 for the isolation and discovery of Vitamin C. Known as the “Father of Nutritional Science”, he also discovered iso-flavones and vitamin P. In his last 40 years, he researched the regulatory processes of cell growth, and thereby the regulation of cancer itself).

Otto Warburg in 1930, has championed the fact that anoxia is the cause of cancer for decades. The first notable experimental induction of cancer by oxygen deficiency was described by Goldblatt and Cameron (1953), who exposed heart fibroblasts in tissue culture to intermittent oxygen deficiency for long periods and finally obtained transplantable cancer cells, whereas in control cultures that were maintained without oxygen deficiency, no cancer cells resulted. Warburg emphasizes, “but there is only one common cause into which all other causes of cancer merge, the irreversible injuring of respiration.” I will present evidence later that this change in cell respiration may not be irreversible after all.

One of the many mysteries about muscles is the fact that they rarely develop cancer. This may be because they are so dependent on oxygen and oxidative metabolism or so rich in mitochondria, the power centres of the cell, that there is too much oxidative reserve for cancer to develop.

It is now well accepted that most cancers are more glycolysis-dependent than normal cells. Cancer cells have lost their capacity to conduct oxidations, and also the mechanisms that use the energy of oxidation for useful work. Instead a low-grade process, wasteful fermentation, is used to produce energy. As stated above, this may be the norm for the cell when it wants to divide. Positron emission tomography (PET) imaging has now confirmed that most malignant tumours have increased glucose uptake and metabolism. Warburg suggested, but did not prove, that this was due to ‘‘abnormal mitochondria’’ (Warburg, 1930); that is, cancer cells are forced to use inefficient, non-mitochondrial means of generating ATP (the energy unit of cells). Szent-Gyorgyi was also of the opinion that this apparent mitochondrial ‘‘dysfunction’’ is in fact reversible. It was his research that suggested that this fermentation energy is transferred to the mitotic mechanism, where it forces cell division. In other words as stated earlier, efficient oxidative energy production is associated with organised cell structure, whereas fermentation is associated with lack of structure and the inclination to cell division. When cancer cells multiply they are merely performing an innate function.

It has been reported that human cancer cell lines have a more negative membrane potential compared to several non-cancerous cell lines, suggesting that this might be a hallmark of malignancy (Bonnet et al, 2007). Since a significant proportion of cell energy production (70% or more) is channelled towards maintaining electrical integrity by supporting the ion pumps at the cell membrane, it becomes clear that this abnormal membrane potential of cancer cells is likely to be secondary to the cell being “metabolically” compromised.

Mitochondrial Function and cancer

Mitochondria are the seat of energy production in the cell producing 80% of the energy needs of the cell. Several differences have been observed between the mitochondria of cancer cells and those of normal cells. It has been suggested that mutations in mitochondria might cause cancer (Woods & DuBuy, 1945). More recently it has been shown that mitochondria are integrally involved in apoptosis or programmed cell death (Petit & Kroemer,1998; Zamzami et al, 1996). The mitochondria contain their own DNA (less then 1% of nuclear DNA), which seems to be more susceptible to damage and mutations than nuclear DNA. The accumulation of mutations in mitochondrial DNA has also been suggested to play a causative role in ageing. Various tumour cell lines exhibit differences in the number size and shape of mitochondria relative to normal controls. The mitochondria of rapidly-growing tumours tend to be fewer in number, smaller and have fewer internal folds than mitochondria of slowly growing tumours. Alterations in the inner membrane composition of tumour mitochondria have also been noted (Modica-Napolitano & Singh, 2002). The mitochondrial membrane potential of cancer cells is approximately 60mV higher than that of control epithelial cells (Modica-Napolitano & Aprille, 1987). Mitochondrial dysfunction is one of the most profound features of cancer cells.

Cancer progression and its resistance to treatment depend, at least in part, on suppression of apoptosis (programmed cell death). As stated above, mitochondria are recognized as regulators of apoptosis.

We have already established that cancer seems to be associated with a glycolytic phenotype. Furthermore, it appears that glycolytic phenotype is indeed associated with a state of apoptosis resistance (Plas and Thompson, 2002). Many glycolytic enzymes have been recognized to also regulate apoptosis, and several oncoproteins induce the expression of glycolytic enzymes (Kim and Dang, 2005).

All the available evidence suggests that if we want to understand cancer better and find a remedy then we have to turn our attention specifically to mitochondria, for it is here that the energy malfunctions that occur in cancer are to be found.

Mitochondrial changes have multiple downstream effects, beyond energy production, because mitochondria regulate several critical functions including calcium concentration and free radical (Reactive Oxygen Species, ROS)-redox control. Mitochondria have an important role in apoptosis that may explain the apoptosis resistance that occurs in many human cancers.

Cancer cells have been shown to have more hyperpolarized mitochondria and were relatively deficient in potassium channels. If this metabolic-electrical remodelling is an adaptive response, then its reversal might increase apoptosis and inhibit cancer growth. The Michelakis research group showed that dichloroacetate (DCA), a small, orally available small molecule and a well-characterized inhibitor of the key enzyme in the glycolytic chain, pyruvate dehydrogenase, was able to change the metabolism of cancer cells from the cytoplasm-based glycolysis to the mitochondria-based glucose oxidation. DCA also reversed the inhibition of potassium channels in all cancer, but not normal cells. The net effect was a reversal of resistance to apoptosis (Bonnet et al, 2007). DCA treatment significantly increases glucose oxidation (which only occurs in functional mitochondria), indicating that the metabolic cancer signature (aerobic glycolysis) is reversible, rather than a consequence of permanent mitochondrial damage. Szent-Gyorgyi concluded this but this was also the conclusion of Koch (1958, see below) whose work strongly suggested that the metabolic/mitochondrial abnormality in cancers could be reversed. DCA was shown to significantly decrease tumour growth in rats without toxic effects. At this time, though approved as a drug treatment for mitochondrial diseases in humans, and apart from anecdotal reports, there are no formal clinical trials in patients with cancer.

Dr. William Koch’s research (1958) focused on the means to restore the body’s oxidation mechanism back to its original vitality, thereby re-equipping the body with its innate ability to restore and maintain health, not only in cancers but also in a host of other diseases.

Organized Medicine launched a fifty-year assault aimed at discrediting Dr. Koch’s reputation, medical practice and research, along with those of any physician who dared to validate his Theories or use his Reagents. Dr Koch’s theories emphasized the relationship between environmental toxins, dietary deficiencies and a depleted oxidation mechanism, as primary initiators of the disease process.

In his work he discovered that removal of the parathyroid gland of animals led to accumulation of toxic substances in the body. He also observed that the urine of the animals without parathyroid glands carried large amounts of lactic acid, which meant that the oxidation process was badly handicapped by the substances that were produced in the parathyroidectomized animals. These substances had blocked the normal tissue oxidation process. This turned out to be a momentous discovery, which paved the way for his original cancer research. By studying the tissues that survived the longest, he found out that the common feature was the presence of the di-carbonyl groups. He postulated that the toxic amines of various metabolic, bacterial, viral or of fungal agents (present day antibiotics included) are able to cripple these important carbonyls by condensing with them. These functional carbonyls were crucial to the preservation of electron transport and metabolic function of the cell but when they were complexed by toxins this could lead to an irreversible compromise of metabolic function. Unfortunately Dr. Koch was never given the research facilities and cooperation by the medical profession he had asked for and wanted.

Despite several cases of advanced cancers being treated successfully by Koch (by the injection of carbonyl compounds) in 1919 under the auspices of the Wayne County Medical Society branch of the American Medical Association (AMA), the Journal of the A.M.A. published over 20 negative editorials and articles about Dr. Koch and his treatment dating back to February 12, 1921.

In 1968, Dr. Szent-Gyorgyi also wrote about the cancerostatic action of carbonyl compounds (Szent-Gyorgyi et al, 1967) and how they are able to arrest cell division. He described these substances in urine and also in tissue extracts from several body organs. His research suggested that these substances when present are not only able to inhibit cell proliferation but also to maintain cells in a normal oxidative metabolism. The suggestion is that the body can lose its ability or become compromised in its ability to produce these substances thereby encouraging the development of cancer.

Further evidence that compromised mitochondrial function is a fundamental cause of the development of cancer is also suggested by the reported efficacy of the Kucera cancer support regime. Dr Michael Kucera, a Czech physician, has spent 20 years or more researching mitochondrial medicine and has developed a nutritional combinations for mitochondrial support (Personal communication, 2009). A combination of these nutrients with specific immune support nutrients has led to remarkable success in cancer remissions. Over 700 cancer patients have been treated with this regime during the last 10 years. These have been patients with variable cancers, most of them non-localised i.e. they have already spread (including breast, prostate, colon and gastric cancers). Overall a 70% remission at 5 years is reported and an 80-90% remission when the formulas are combined with chemotherapy. No side effects were observed. Compare this to the efficacy of chemotherapy of 2-3% and with significant side effects. To my knowledge this may be the most effective treatment regime available and is the regime of choice used in my own clinic. It is even more remarkable that the regime is a purely oral-based regime. The fundamental basis for this high level of efficacy must be due to the core benefit to the mitochondria.

Coenzyme Q10 will be more familiar to many of you. This fat-soluble substance is present in most eukaryotic cells, primarily in the mitochondria. It is a component of the electron transport chain and participates in aerobic cellular respiration, generating energy in the form of ATP. Ninety-five percent of the human body’s energy is generated this way (Ernster & Dallner, 1995; Dutton et al, 2000) Therefore, those organs with the highest energy requirements—such as the heart and the liver—have the highest CoQ10 concentrations (Okamato et al, 1989; Aberg et al, 1992; Shindo et al, 1994).

Interest in coenzyme Q10 as a potential therapeutic agent in cancer was stimulated by an observational study that found that individuals with lung, pancreas, and especially breast cancer were more likely to have low plasma coenzyme Q10 levels than healthy controls (Folkers et al, 1997). There are a few case reports and an uncontrolled trial (see below) suggesting that coenzyme Q10 supplementation may be beneficial as an adjunct to conventional therapy for breast cancer (Hodges et al, 1999).

Although CoQ10 is best documented in the treatment of heart failure, two medical journal articles suggest tremendous promise in the treatment of cancer. Folkers (1997) described 10 cancer patients given CoQ10 for heart failure. One of the patients, a 48-year-old man diagnosed with inoperable lung cancer, had no signs of either cancer and heart failure symptoms while taking CoQ10 for 17 years.

Knud Lockwood, M.D (1994), a cancer specialist in Copenhagen, Denmark, described his treatment of 32 “high-risk” breast cancer patients with antioxidant vitamins, essential fatty acids, and CoQ10. “No patient died and all expressed a feeling of well-being,” he wrote “These clinical results are remarkable …..After 24 months, all still survived; about 6 deaths would have been expected.” Six of the 32 patients showed partial tumour remission, and two benefited from very high doses of CoQ10. One, a 59-year-old woman with a family history of breast cancer, had a tumour recurrence 1.5-2 centimetres in diameter but one month after increasing the CoQ10 intake to 390 mg. daily, the tumour had disappeared. Mammography confirmed its absence. Another patient, age 74, had a small tumour removed from her right breast. She refused a second operation to remove additional growths and began taking 300 mg of CoQ10 daily. Three months later, an examination and mammography revealed no evidence of the tumour or metastases. Lockwood, who has apparently treated some 7,000 cases of breast cancer over 35 years, wrote that until using CoQ10, he had “never seen a spontaneous complete regression of a 1.5-2.0 centimetre breast tumour, and has never seen a comparable regression on any conventional anti-tumour therapy.”

Although none of the above are controlled studies they provide circumstantial evidence for my hypothesis that mitochondrial metabolic malfunction are critical to cancer development and should be the primary target in the war against cancer. Indeed, I have presented evidence from several pioneering doctors/researchers to show that when the mitochondria are supported and/or their metabolic defect is corrected that this is associated with cancer remissions. I am not the first to suggest this but I cannot ignore the evidence before me. I am convinced that this is the key to unravelling the cancer mystery. History has given us the clues…..it is time to stop ignoring them!

It was not the purpose of this article to focus on anything but the physical side of treatment but it would be an omission in the context of the title of this article “Winning the war on cancer” not to at least comment on the role of belief and positive thought to influence positive outcome in the war. This important component has been discussed elsewhere (Byrne, 2006; Chopra, 1989).

 

ARE YOU VITAMIN D DEFICIENT?

Have you noticed how sensitive the Towie cast are to jokes about their fake tans. They should lighten up…. Meanwhile us deliberately pale and genetically pale types need to get serious about vitamin D deficiency. Health experts claim it’s an epidemic waiting to happen.

I met one of the world’s leading anti-ageing doctors, Dr Nyjon Eccles, late last year before a trip to Verdura, above, where he oversees the excellent Vita Health programme. He estimated that about 70% of us are Vitamin D deficient – including many who have tans (using sun creams blocks the beneficial effects of sunlight).

Why does it matter? Because vitamin D (which is a hormone rather than a vitamin, by the way) protects the body against the degenerating effects of inflammation, which can contribute to all sorts of conditions including cancer and heart disease. Our lack of vitamin D has led to a new word inflamm-ageing – as soon as the medical world coins a trendy term, you know you have to take it seriously. Dr Eccles takes 5,000 i u (international units) of vitamin D daily. Tests showed I was deficient and I now dose up every day  too. Dr Eccles thinks everyone should be tested. I’m glad I have been.

GD Biosciences Announces Availability of the PULS Cardiac Test in London, UK

Global Discovery Biosciences (GD Biosciences), developer of The PULS Cardiac Test, a 9-protein biomarker based blood test that detects and diagnoses early-stage heart disease in asymptomatic patients, today announced its strategic partnership with The Natural Doctor to help bring prevention and enhanced detection methods direct to London, UK. The announcement is part of a strategic international expansion plan. The company launched the PULS Cardiac Test in India just last month.

“The PULS Cardiac Test is a powerful diagnostic and predictive assessment that has demonstrated significant improvement in identifying patients with early stage cardiac lesions and has been validated in a multi-ethnic population,” said Douglas S. Harrington, M.D., CEO of GD Biosciences and co-developer of the PULS Cardiac Test. “With its ongoing success in the U.S., the PULS Cardiac Test aims to catalyze improved cardiac disease detection and management around the world.”

The PULS Cardiac Test has seen significant growth in the U.S. since its launch earlier this year. As an affordable blood test, reimbursed by most healthcare insurance in the US, it is a breakthrough in disease management and prevention.

Eighty percent of heart disease is preventable through healthy lifestyle choices, education and early detection.

Dr. Nyjon Eccles, founder of the Natural Doctor in London UK, comments:

“Since 1998, I have been practicing Preventative Medicine. The Medical profession tends to use tests that are not sensitive enough for early detection, hence, we tend to detect disease late in the day when it is well established. Fifty percent of people who have a heart attack have normal cholesterol levels and this highlights the fact that the current cardiovascular risk blood markers that we doctors use are missing a large proportion of people at risk. I believe that the PULS Cardiac Test will prove a game-changer in this respect”.

“The Natural Doctor is excited to be working with GD biosciences, since part of our mission is to help prevent diseases through early detection, education and offering non-invasive, cost effective solutions to keep people away from diseases like heart disease”.

The Natural Doctor will be the sole representative of GD Biosciences for their PULS Cardiac Test in the UK.

Anyone interested in knowing more about this test can email queries to info@thenaturaldoctor.org

About GD Biosciences

Global Discovery Biosciences is a pioneer in the field of diagnostic medicine. The company works on the cutting edge of medical research, turns discoveries into innovative products and brings those products to the global marketplace.

The company works with advanced research teams to develop, manufacture and distribute innovative technology platforms to address the needs of the global disease burden. Its CLIA-certified and GMP laboratory performs a menu of clinically effective tests targeting key health issues. Our goal is to equip physicians with the tools they need to transform health care – one patient at a time.

About the PULS Cardiac Test

The PULS Cardiac Test is a simple blood test that uses breakthrough medical technology to identify individuals with active, yet undetected subclinical Coronary Heart Disease (CHD), who are at risk of experiencing a Heart Attack, and for whom early intervention can help. Check out our recent news coverage:

Fox News Special Report – Technology Helps Predict Heart Attacks

Travel Pulse – Could Blood Test Warn Pilots of Heart Attack Risk?

Times Colonist – Blood test can assess heart attack risk, conference told

Saskatoon Star Phoenix – New test for heart attack risk

The Province – Blood test can assess heart attack risk, Vancouver conference hears